2010
DOI: 10.1016/j.bmc.2009.10.057
|View full text |Cite
|
Sign up to set email alerts
|

Solid phase synthesis of novel asymmetric hydrophilic head cholesterol-based cationic lipids with potential DNA delivery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
18
0

Year Published

2010
2010
2022
2022

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 22 publications
(19 citation statements)
references
References 33 publications
1
18
0
Order By: Relevance
“…The transfection efficiency of the cationic liposome also depends on the cationic lipisomes/DNA ratio as previously reported by our group 19,33,34) and others. [35][36][37] To find out the optimal liposomes/DNA ratio, transfection experiments were performed against HEK293 cells by using mixture lipids/ DOPE ratio of 1 : 1.…”
Section: )supporting
confidence: 76%
See 1 more Smart Citation
“…The transfection efficiency of the cationic liposome also depends on the cationic lipisomes/DNA ratio as previously reported by our group 19,33,34) and others. [35][36][37] To find out the optimal liposomes/DNA ratio, transfection experiments were performed against HEK293 cells by using mixture lipids/ DOPE ratio of 1 : 1.…”
Section: )supporting
confidence: 76%
“…19,33,34) To evaluate the transfection efficiency of these mixture lipids toward the different cell lines, human breast adenocarcinoma (MCF-7) and cervical epithelial adenocarcinoma (HeLa) cells, the experiments were performed by using optimum condition under serum-free conditions. The transfection efficiency of mixture lip- ids was compared with the commercially available transfection agent, Lipofectamine 2000, which was calculated as 100%.…”
Section: )mentioning
confidence: 99%
“…[22,24,30] To find out the optimal ratio of each lipid, transfection experiments were performed against HEK293 cells by using optimal lipid/DOPE ratio of each compound, as shown in Figure 3. The optimal N/P ratios are shown in Figure 4.…”
Section: Transfection Biologymentioning
confidence: 99%
“…Guanidines have the extra advantage, being bidentate, of being able to form two hydrogen bonds with negatively charged groups e.g., carboxylates, phosphates or sulfates present on the carbohydrates associated with the cell membrane, and this advantage has been used in vectors e.g., R8, Arg 8 [11,12] to transport cargoes across cell membranes. These characteristics led to the design of many non-viral vectors for DNA and siRNA, varying from cationic lipids incorporating guanidine head-groups [13-15] e.g., AtuFECT [15], to cationic polymers [16,17] and dendrimers [18,19], to carbohydrate derivatives [19,20], and hydrogels of guanidinylated hyaluronic acid [21]. The use of guanidinium-containing lipid based carriers for gene delivery dates back to 1996 where Lehn et al synthesized two guanidinium cholesterol lipids: bis-guanidiniumspermidine-cholesterol (BGSC) and bis-guanidinium-trencholesterol (BGTC), each containing two guanidine groups, which were synthesized and evaluated for their DNA transfection efficiencies in eukaryotic cells (Figure 1) [22] where they were found to be efficient DNA transfecting agents.…”
Section: Introductionmentioning
confidence: 99%